title: Marked Differences in CNS Activity among EGFR Inhibitors: Case Report and Mini-Review.
authors.affiliation: Department of Medicine, Albert Einstein Cancer Center/Montefiore Medical Center Bronx, New York.
authors.forename: Vipul
authors.initials: V
authors.lastname: Pareek
authors.affiliation: Department of Medicine, Albert Einstein Cancer Center/Montefiore Medical Center Bronx, New York.
authors.forename: Mary
authors.initials: M
authors.lastname: Welch
authors.affiliation: Department of Medicine, Albert Einstein Cancer Center/Montefiore Medical Center Bronx, New York.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Ravera
authors.affiliation: Department of Radiology, Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, New York.
authors.forename: Richard L
authors.initials: RL
authors.lastname: Zampolin
authors.affiliation: Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Lecia V
authors.initials: LV
authors.lastname: Sequist
authors.affiliation: Department of Medicine, Albert Einstein Cancer Center/Montefiore Medical Center Bronx, New York. Electronic address: bahalmos@montefiore.org.
authors.forename: Balazs
authors.initials: B
authors.lastname: Halmos
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D002490:Central Nervous System / Q000187:drug effects*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors